Extracting and analyzing relevant medical information from large-scale databases such as biobanks poses considerable challenges. To exploit such "big data," attempts have focused on large sampling ...

Investigators in the Nancy Guthrie case have turned to genetic genealogy as they try to make the most of potential DNA ...

In pet genetics, cancer research, and beyond, Charlie Lieu, MBA ’05, SM ’05, has spent her career harnessing massive data ...

Live Science spoke with a bioethicist and sociologist about emerging genomic technologies, including those that enable ...

AI-powered gene maps reveal the hidden control centers driving Alzheimer’s disease — and point to new hope for treatment.

For the first time, researchers have succeeded in developing an artificial DNA base pair that is based on a different chemical force than natural genetic material. While the common natural DNA ...

Researchers have found that a new base-editing gene therapy can help treat a rare neurodevelopmental disorder called Snijders Blok–Campeau syndrome caused by mutations in the CHD3 gene. A specialized ...

It takes two to tango, and two to trigger Parkinson’s. New research identifies the "partners in crime" genes that work together to overwhelm the brain’s waste-management system.

The FDA has said it will reduce the regulatory requirements on the manufacturing of cell and gene therapies (CGTs) in order to make it easier for developers to bring them to market. Specifically, the ...

Gene-editing specialist Seamless Therapeutics has attracted its first major pharma partner, Eli Lilly, with a $1.12 billion alliance that will seek out therapies for hearing loss.

This project has been funded with federal funds under Contract No. HHSN263201800029I (75N98021F00009) between the National Academy of Sciences and the Department of Health and Human Services, National ...